Texas Facility
Eli Lilly Invests $6.5 Billion in Texas Facility to Manufacture Obesity Pill
Eli Lilly; Texas facility; obesity pill; orforglipron; pharmaceutical manufacturing; API; AI automation; supply chain resilience; job creation
Actionable Insights Powered by AI
Eli Lilly; Texas facility; obesity pill; orforglipron; pharmaceutical manufacturing; API; AI automation; supply chain resilience; job creation